Leonar, Hanah M.
HRN: 13-81-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/03/2023
08/10/2023
IV
1.5g
Q6H
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes